A11T (p.Ala11Thr) variant of GCK (Hexokinase-4)

A11T (p.Ala11Thr) in GCK (Hexokinase-4) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as benign in the context of Monogenic diabetes. The available variant effect predictions contribute to a CATVariant prioritization score of 0.22 / 1. The record also includes population frequency data, published literature, and structural context.

A11T (p.Ala11Thr) variant details